<DOC>
	<DOCNO>NCT01459900</DOCNO>
	<brief_summary>The purpose double blind , randomize sham control study determine whether renal denervation term catheter base ablation renal artery effective lower blood pressure patient treatment resistant hypertension . The blood pressure lower effect evaluate 24 hour ambulatory blood pressure measurement baseline 1 , 3 6 month follow . Secondary end point evaluation concern hemodynamic measure use echocardiography , applanation tonometry forearm plethysmography .</brief_summary>
	<brief_title>Renal Sympathectomy Treatment Resistant Essential Hypertension , Sham Controlled Randomized Trial</brief_title>
	<detailed_description />
	<mesh_term>Hypertension</mesh_term>
	<criteria>Systolic daytime ambulatory BP least 145 mmHg compliance minimum 3 antihypertensive drug , include diuretic , case diuretic intolerance least 3 nondiuretic antihypertensive drug . Pregnancy Non compliance Heart Failure ( NYHA 34 ) LV ejection fraction &lt; 50 % Renal insufficiency ( eGFR &lt; 30 ) Unstable coronary heart disease Coronary intervention within 6 month Myocardial infarction within 6 month Claudication Orthostatic syncope within 6 month Secondary Hypertension Permanent atrial fibrillation Significant Heart Valve Disease Clinically Significant abnormal electrolyte , haemoglobin , Liver enzymes , TSH Second third degree heart block Macroscopic haematuria Proximal significant coronary stenosis Renal artery anatomy suitable renal artery ablation ( Stenosis , small diameter &lt; 4 mm , length &lt; 2 cm , multiple renal artery , severe calcification )</criteria>
	<gender>All</gender>
	<minimum_age>30 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>September 2016</verification_date>
	<keyword>Treatment Resistant Hypertension</keyword>
</DOC>